Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AUDIANCE INC
- Proposal award date
- 2021-03-10
- Contract end date
- 2023-02-28
- UEI
- KGWLUNY5AE66
- Solicitation number
- PA20-260
- Topic code
- NIDCD
Research abstract
PROJECT SUMMARY
Severe to profound sensorineural hearing loss (SNHL), caused by disease, aging, ototoxicity,
head trauma and heredity, affects about 60 million worldwide, and is expected to reach around
100 million by 2050. This disability leads to a significantly lowered quality of life and a large
economic burden, estimated to be around $750 billion worldwide, coming from health sector
costs, educational support, and loss of workplace productivity. For this population, amplification
with even the most sophisticated hearing aids is usually ineffective, and restorative biological
therapies are years away. A cochlear implant is currently the only available route for restoring
‘adequate’ functionality. Only 600,000 implants have been done worldwide till 2019, and about
50,000 devices are being sold annually. This large discrepancy between those that can benefit
and those that actually get the implant is driven partly by their cost, availability and the lack of
trained surgeons and facilities. However, there are several limitations in the current devices that
contribute to very low adoption: (a) The highly visible unit attached to the skull outside the
mastoid bone, connected by a cable to the sound processor and rechargeable battery placed
behind the ears, makes the disability very obvious, and creates an unacceptable social stigma
for many patients, causing them to refuse this option; (b) Sound filtering by the auricle and
auditory canal is bypassed because of the external microphone, introducing unnatural cues; (c)
The device typically must be taken off during showering or swimming (although a few water-
resistant versions are now available), and during sleeping, increasing the likelihood of damage,
misplacement, or the ability to hear in these situations; (d) Having an external magnet that
couples and aligns the internal and external components can lead to skin breakdown and
implant extrusion; (e) The large footprint and placement leaves open the risk for device
migration requiring revision surgery. A fully internal cochlear implant (FICI), that does not have
any behind the ear components, would address this large unmet medical need.
There are no FICIs currently approved by the FDA. The lack of a self-contained power supply is
a key roadblock preventing realization of all FICIs. Through innovations in circuit design and
signal processing, collaborating groups at Massachusetts Eye and Ear and Massachusetts
Institute of Technology have developed, tested and patented a low power (1 mW) system-on-a-
chip (SoC) for a FICI, a critical advance. Current rechargeable batteries have organic liquid
electrolytes making them unsafe for this application. With SBIR Phase I funding, Audiance, Inc.
has shown proof of concept of an all-solid single-stack cell that is the building block for a battery
that meets the electrochemical, safety and footprint requirements for a FICI. The focus of this
SBIR Phase II project is to build a multi-stack wirelessly rechargeable battery and integrate it
with a battery management system that senses the state of health of the battery and controls
the charge profile to provide timely charging and maximum battery life. The all-solid LIB will
remove a critical roadblock for the development of a FICI, and thus open up an opportunity to
help millions of patients around the world with severe to profound SNHL. The learning from the
design and fabrication of this battery will allow Audiance to customize batteries for a range of
other active implantable medical devices.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
3 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $1,162,322. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Aeronautics and Space Administration
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards